Table: begin end state 1 11 cytoplasmic 12 30 transmembrane 31 67 non-cytoplasmic 68 91 transmembrane 92 99 cytoplasmic 100 121 transmembrane 122 126 non-cytoplasmic 127 127 cytoplasmic 128 145 transmembrane 146 159 cytoplasmic 160 181 transmembrane 182 186 non-cytoplasmic 187 207 transmembrane 208 247 cytoplasmic 248 267 transmembrane 268 287 non-cytoplasmic 288 311 transmembrane 312 325 cytoplasmic 326 342 transmembrane 343 347 non-cytoplasmic 348 369 transmembrane 370 380 cytoplasmic 381 406 transmembrane 407 411 non-cytoplasmic 412 434 transmembrane 435 441 cytoplasmic
Input: >Echvi_3106 MVKIKLNSIIKGYRWRIVALLFLATAIKYIDRNVLSFTMIDEGFRREMLGVSDTTALSSE LIGKFKILMGYVDASFKFAYAIGFVLMGYFIDRVLVRKGYSIAIAIWSLAGIVTAFVSSF RGLSFTRFVFGFGESANFPAAIKTIAEWFPKKERSFATGIYNAGANVGIMATVLIVPALI LNLGWRWSFLCTGLLGLVLLACWLLIYKPPKAHPKVSQDEQEHIHADEESEHEAEKVPWK DLLKTKGAWAIALGKFLTDPIWWFYLTWLPDFFNSNEALETKLDLTGLALPFIFIYFTSD LGSVFFGWLSGKFINMGWSLNKSRKVTLLLCALLVVPLIFAAKVANVYVAMVLVALAAAA HQGWSANLFTLSSDIFPKRVVGSVVGLAGMVGGIGGTIFAAFAGIILVKWGYFPIFIIAS SAYLLAWLIIHLLVPKIGVRS
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server